1. Home
  2. CTNM vs WNC Comparison

CTNM vs WNC Comparison

Compare CTNM & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Contineum Therapeutics Inc.

CTNM

Contineum Therapeutics Inc.

HOLD

Current Price

$11.68

Market Cap

416.1M

Sector

N/A

ML Signal

HOLD

WNC

Wabash National Corporation

HOLD

Current Price

$9.86

Market Cap

363.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CTNM
WNC
Founded
2009
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
416.1M
363.8M
IPO Year
2024
1991

Fundamental Metrics

Financial Performance
Metric
CTNM
WNC
Price
$11.68
$9.86
Analyst Decision
Buy
Hold
Analyst Count
5
1
Target Price
$18.60
$9.00
AVG Volume (30 Days)
234.6K
479.7K
Earning Date
03-05-2026
02-04-2026
Dividend Yield
N/A
3.29%
EPS Growth
N/A
N/A
EPS
N/A
6.15
Revenue
N/A
$1,638,115,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$15.44
P/E Ratio
N/A
$1.58
Revenue Growth
N/A
N/A
52 Week Low
$3.35
$6.78
52 Week High
$13.49
$16.91

Technical Indicators

Market Signals
Indicator
CTNM
WNC
Relative Strength Index (RSI) 59.75 53.21
Support Level $11.00 $9.63
Resistance Level $12.29 $11.11
Average True Range (ATR) 0.86 0.50
MACD 0.22 0.01
Stochastic Oscillator 96.21 51.79

Price Performance

Historical Comparison
CTNM
WNC

About CTNM Contineum Therapeutics Inc.

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

About WNC Wabash National Corporation

Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.

Share on Social Networks: